继续使用华法林与转换为直接口服抗凝药患者的社会人口学因素比较
该前瞻性队列纳入密歇根州6家抗凝门诊的8468例新启用华法林成人患者,比较继续华法林者与转换为直接口服抗凝药(DOAC)者的社会人口学因素。696例(8.2%)转换为DOAC;转换者中白人比例、有伴侣比例及邮政编码中位家庭收入更高,而治疗范围内国际标准化比值时间百分比、城乡居住状态和医疗保险无显著差异。
要点
- 8468例新启用华法林患者中,696例(8.2%)转换为DOAC。
- 转换者白人比例83.3% vs 非转换者77.7%(P < .001),有伴侣比例67.3% vs 59.2%(P < .001)。
- 转换者居住地邮政编码中位家庭收入更高(P < .001);治疗范围内INR时间百分比、城乡状态和医疗保险无显著差异。
核心结论
- 种族、伴侣状态和收入等社会人口学因素与患者从华法林转换为DOAC的可能性相关。
- 临床因素占主导,但观察到的诊疗差异的原因和影响需进一步研究。
研究设计与样本
- 前瞻性队列研究,纳入密歇根州6家抗凝门诊新启用华法林的成人患者,共8468例。
- 8468例中53.3%为心房颤动(AF),45.6%为静脉血栓栓塞症(VTE),1.1%两者均有。
- 比较继续使用华法林者与转换为DOAC者的社会人口学变量。
主要发现
- 696例(8.2%)从华法林转换为DOAC。
- 转换者与非转换者华法林治疗范围内国际标准化比值时间百分比无显著差异。
- 转换者与非转换者城乡居住状态无显著差异。
- 转换者与非转换者医疗保险无显著差异。
- 转换者白人比例83.3% vs 非转换者77.7%(P < .001)。
局限性
- 观察到的诊疗差异的原因和影响需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical factors and patient preferences are important for selecting oral anticoagulants for venous thromboembolism (VTE) and atrial fibrillation (AF). The relative association of sociodemographic factors with anticoagulant use is unknown. We evaluated a prospective cohort to compare sociodemographic variables in patients who continued on warfarin for AF or VTE to those who transitioned to 1 of the direct oral anticoagulants (DOACs). Adult patients, newly started on warfarin, were enrolled through 6 anticoagulation clinics across Michigan. Of 8468 patients, 53.3% had AF, 45.6% had VTE, and 1.1% had both. Of these, 696 (8.2%) switched from warfarin to a DOAC. There were no significant differences between switchers and nonswitchers for percentage of time with a therapeutic international normalized ratio on warfarin, urban-rural residence status, or health insurance. Switchers were more often white (83.3% vs 77.7%; P < .001), partnered (67.3% vs 59.2%; P < .001), or resided in a zip code with a higher median household income (P < .001). The results show that sociodemographic factors, such as race, partnered status, and income are associated with a patient's likelihood of switching to a DOAC vs remaining on warfarin therapy. Although clinical factors predominate, the reason for, and impact of, these observed variations in care requires further investigation.
引用
- Schaefer JK, Sood SL, Haymart B, et al. Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Adv. 2017. PMID: 29296905. doi:10.1182/bloodadvances.2017012377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。